1
|
Suner L, Sourdeau E, Ranaweera T, Tarfi S, Ronez E, Trichet C, Chapuis N, Lefebvre T, Debliquis A, Boyer T, Sandrine G, Mestrallet F, Broutier H, Dindinaud E, Rault E, Reinhard-Chegaray AS, Delhommeau F, Bardet V. Clinical and biological characteristics of patients presenting with carcinocythaemia: A retrospective, multicentre study by the French-speaking Cellular Hematology Group (GFHC). Br J Haematol 2024. [PMID: 39183701 DOI: 10.1111/bjh.19728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2024] [Accepted: 08/13/2024] [Indexed: 08/27/2024]
Affiliation(s)
- Ludovic Suner
- Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, Hôpital Saint-Antoine, Service d'Hématologie Biologique, Paris, France
| | - Elise Sourdeau
- Sorbonne Université, Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, APHP, Paris, France
| | - Thimali Ranaweera
- Hematology and Immunology Department, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France
| | - Sihem Tarfi
- Hematology and Immunology Department, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France
| | - Emilie Ronez
- Service d'Hématologie-Immunologie-Transfusion, CHU Ambroise Paré, INSERM UMR 1184, AP-HP, Université Versailles Saint-Quentin -Université Paris Saclay, Boulogne Billancourt, France
| | - Catherine Trichet
- Service d'Hématologie Biologique, Hôpital Beaujon, AP-HP Nord Université de Paris, Clichy, France
| | - Nicolas Chapuis
- Assistance Publique-Hôpitaux de Paris, Centre-Université Paris Cité, Service d'hématologie Biologique, Hôpital Cochin, Paris, France
| | - Thomas Lefebvre
- Laboratoire d'Hématologie, Hôpitaux Civils de Colmar, Colmar, France
| | - Agathe Debliquis
- Laboratoire d'Hématologie, Groupe Hospitalier de la région Mulhouse Sud Alsace, Mulhouse, France
| | - Thomas Boyer
- Service d'Hematologie Biologique, CHU Amiens, Amiens, France
| | - Girard Sandrine
- Service d'Hématologie Biologique, Centre de Biologie et de Pathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
| | - Fanélie Mestrallet
- Service d'Hématologie Biologique, Centre de Biologie et de Pathologie Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
| | - Hélène Broutier
- Laboratoire d'Hématologie, Grand Hôpital de l'Est Francilien, Meaux, France
| | | | | | | | - Francois Delhommeau
- Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS, Hôpital Saint-Antoine, Service d'Hématologie Biologique, Paris, France
| | - Valérie Bardet
- Service d'Hématologie-Immunologie-Transfusion, CHU Ambroise Paré, INSERM UMR 1184, AP-HP, Université Versailles Saint-Quentin -Université Paris Saclay, Boulogne Billancourt, France
| |
Collapse
|
2
|
Zhang Y, Li X, Li X, Li X, Gan W, Li T. Concurrent carcinocythemia, chest wall and right knee joint involvement in Ewing sarcoma. Pediatr Blood Cancer 2023; 70:e30519. [PMID: 37337073 DOI: 10.1002/pbc.30519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Revised: 06/07/2023] [Accepted: 06/09/2023] [Indexed: 06/21/2023]
Affiliation(s)
- Yun Zhang
- Department of Clinical Laboratory, The District People's Hospital of Zhangqiu, Jinan, China
| | - Xuemei Li
- Department of Medical Ultrasound, The District People's Hospital of Zhangqiu, Jinan, China
| | - Xue Li
- Department of Health Ward, The District People's Hospital of Zhangqiu, Jinan, China
| | - Xiaohong Li
- Department of Clinical Laboratory, The District People's Hospital of Zhangqiu, Jinan, China
| | - Wenxue Gan
- Department of Laboratory Medicine, Beijing Ludaopei Hospital, Beijing, China
| | - Ting Li
- Department of Laboratory Medicine, Beijing Ludaopei Hospital, Beijing, China
| |
Collapse
|
3
|
Chan WK, Lin NS, Tay KV, Teo LT. Systematic review of isolated disseminated carcinomatosis of bone marrow from colorectal cancer. ANZ J Surg 2023; 93:1169-1175. [PMID: 36772885 DOI: 10.1111/ans.18324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2022] [Revised: 01/29/2023] [Accepted: 01/31/2023] [Indexed: 02/12/2023]
Abstract
BACKGROUND Colorectal cancer (CRC) metastasis commonly occurs in the liver and lungs with bone metastasis rarely occurring in isolation. Disseminated carcinomatosis of bone marrow (DCBM) is extremely rare in CRC. We conducted a systematic review to provide more information on the diagnosis, treatment options, and prognosis of the condition. METHODS Studies were identified by performing searches on MEDLINE and EMBASE electronic databases according to the PRISMA statement standards. We included a single patient whom we treated for metastatic CRC presenting with DCBM in our study. Statistical analysis was performed using SPSS software version 23.0. RESULTS A search through 5502 unique studies yielded 14 studies that were eventually included. There was a total of 17 cases of DCBM in CRC with back pain and constitutional symptoms as the most common presenting complaints. DCBM in CRC was associated with markedly elevated CEA of 275.57 (95% CI 17.13-534.00). There was no predilection for site of primary tumour. Overall median survival was 120 days (95% CI 64.43-175.58). The median survival for patients who received chemotherapy was 240 days (95% CI 71.11-408.89), as compared to 9 days (95% CI 1.80-16.20) for patients who received best supportive treatment. CONCLUSION DCBM from CRC is extremely rare. Bone marrow examination remains the gold standard for diagnosis. Colonic stenting or surgical diversion may be more appropriate than primary resection in obstructed CRC in view of the poor prognosis. Systemic chemotherapy shows promise in increasing median survival.
Collapse
Affiliation(s)
- Wai Kiu Chan
- Trauma Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore
| | - Norman Sihan Lin
- Trauma Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore
| | - Kon Voi Tay
- Trauma Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore
| | - Li-Tserng Teo
- Trauma Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore
| |
Collapse
|
4
|
Alghandour R, Saleh GA, Shokeir FA, Zuhdy M. Metastatic colorectal carcinoma initially diagnosed by bone marrow biopsy: a case report and literature review. J Egypt Natl Canc Inst 2020; 32:30. [PMID: 32676803 DOI: 10.1186/s43046-020-00040-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Accepted: 05/17/2020] [Indexed: 01/11/2023] Open
Abstract
BACKGROUND Colorectal carcinoma still represents a global health burden despite the advances in its management. The most common sites of distant metastasis from colorectal carcinoma are hepatic and pulmonary metastases while metastases are rarely reported to affect the bone marrow. CASE PRESENTATION We report a 33-year-old female patient who presented with fever of unknown origin, bone aches limited to the lower back and pelvis, and pancytopenia. She was diagnosed by a bone marrow biopsy as a case of metastatic rectosigmoid carcinoma. Serum tumor markers were within normal ranges; CT, MRI, and colonoscopy confirmed the presence of malignant rectosigmoid mass with bone and ovarian metastases. CONCLUSION Though being rare, bone marrow metastasis should be suspected in colorectal carcinoma cases with abnormalities in peripheral blood count.
Collapse
Affiliation(s)
- Reham Alghandour
- Medical Oncology Department, Oncology Center, Mansoura University, Mansoura, Egypt
| | - Gehad A Saleh
- Diagnostic Radiology Department, Mansoura University Hospitals, Mansoura, Egypt
| | | | - Mohammad Zuhdy
- Surgical Oncology Unit, Oncology Center, Mansoura University, Mansoura, 35516, Egypt.
| |
Collapse
|
5
|
Ehara T, Kitazawa M, Hondo N, Takahata S, Yamamoto Y, Koyama M, Okumura M, Nakamura S, Tokumaru S, Muranaka F, Miyagawa Y, Soejima Y. Treatment of Rectal Cancer-Induced Disseminated Carcinomatosis of the Bone Marrow with FOLFOX plus Cetuximab and Panitumumab. Case Rep Oncol 2020; 13:145-152. [PMID: 32231536 DOI: 10.1159/000505323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2019] [Accepted: 12/05/2019] [Indexed: 11/19/2022] Open
Abstract
Disseminated carcinomatosis of the bone marrow (DCBM) in colorectal cancer is an extremely rare complication with a poor prognosis. Here, we report a case of DCBM due to rectal cancer successfully treated with a combination of FOLFOX and an anti-epidermal growth factor receptor (EGFR) agent. The patient was a 38-year-old man diagnosed with rectal cancer with multiple bone and para-aortic lymph node metastases complicated by disseminated intravascular coagulation (DIC). He first recovered from DIC following cotreatment with FOLOX plus cetuximab; subsequently, the second attack was successfully treated with FOLFOX plus panitumumab. His initial condition was extremely poor, but he survived with two FOLFOX plus anti-EGFR regimens and died 333 days after introduction of chemotherapy.
Collapse
Affiliation(s)
- Takehito Ehara
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Masato Kitazawa
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Nao Hondo
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Shugo Takahata
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Yuta Yamamoto
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Makoto Koyama
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Motohiro Okumura
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Satoshi Nakamura
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Shigeo Tokumaru
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Futoshi Muranaka
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Yusuke Miyagawa
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| | - Yuji Soejima
- Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
| |
Collapse
|
6
|
Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM. Carcinocythemia: A rare entity becoming more common? A 3‐year, single institution series of seven cases and literature review. Int J Lab Hematol 2018; 41:69-79. [DOI: 10.1111/ijlh.12924] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2018] [Revised: 07/20/2018] [Accepted: 07/31/2018] [Indexed: 12/20/2022]
Affiliation(s)
- Shira Ronen
- Department of Pathology Medical College of Wisconsin Milwaukee Wisconsin
| | - Steven H. Kroft
- Department of Pathology Medical College of Wisconsin Milwaukee Wisconsin
| | - Horatiu Olteanu
- Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota
| | - Paul R. Hosking
- Department of Pathology University at Buffalo Buffalo New York
| | | |
Collapse
|
7
|
Sá E Lemos E, Lima de Carvalho H, Gil da Costa RM, Pinto da Cunha N. Carcinocythemia: First report in a cat and literature review. Vet Clin Pathol 2018; 47:142-145. [PMID: 29360147 DOI: 10.1111/vcp.12565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
A 6-year-old female neutered European Shorthair cat was presented with a 2-day history of lethargy and hyporexia. On physical examination, the cat was slightly depressed and had a 2.5 cm nodule in the left 3rd mammary gland. The hemogram revealed mild leukocytosis with mature neutrophilia and moderate thrombocytopenia. On blood smear evaluation, rare pleomorphic cells, possibly of epithelial origin, were observed mainly at the feathered edge. The animal died about 12 hours after presentation, and a necropsy was performed. On histopathology, the mammary nodule was diagnosed as a tubulopapillary adenocarcinoma with vascular invasion and widespread metastases. Immunocytochemical tests for cytokeratins (AE1/AE3) confirmed the epithelial phenotype of the neoplastic cells observed on the blood smear. The present report describes a feline mammary carcinoma with widespread metastases and the presence of malignant epithelial cells in the peripheral blood referred to as carcinocythemia. This condition has been previously described in people and dogs. To the author's knowledge, this is the first reported case of feline carcinocythemia. As in other species, the phenomenon was associated with a terminal phase of systemic malignancy.
Collapse
Affiliation(s)
- Eva Sá E Lemos
- CEDIVET - Laboratório Clínico Veterinário, Porto, Portugal
| | | | - Rui M Gil da Costa
- CEDIVET - Laboratório Clínico Veterinário, Porto, Portugal.,LEPABE - Faculdade de Engenharia da Universidade do Porto, Porto, Portugal.,Instituto Português de Oncologia do Porto, Porto, Portugal
| | - Nazaré Pinto da Cunha
- CEDIVET - Laboratório Clínico Veterinário, Porto, Portugal.,ULHT - Faculdade de Medicina Veterinária, Lisboa, Portugal
| |
Collapse
|
8
|
Primary Signet Ring Cell Carcinoma of Rectum Diagnosed by Boring Biopsy in Combination with Endoscopic Mucosal Resection. Case Rep Med 2018; 2018:5860815. [PMID: 29560010 PMCID: PMC5818929 DOI: 10.1155/2018/5860815] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2017] [Revised: 11/16/2017] [Accepted: 11/26/2017] [Indexed: 12/13/2022] Open
Abstract
A 46-year-old man with severe back pain visited our hospital. Magnetic resonance imaging revealed extensive bone metastasis and rectal wall thickness. Colonoscopy revealed circumferential stenosis with edematous mucosa, suggesting colon cancer. However, histological findings of biopsy specimens revealed inflammatory cells but no malignant cells. The patient underwent endoscopic ultrasound, which demonstrated edematous wall thickness without destruction of the normal layer structure. After unsuccessful detection of neoplastic cells by boring biopsies, we performed endoscopic mucosal resection followed by boring biopsies that finally revealed signet ring cell carcinoma. Herein, we present a case and provide a review of the literature.
Collapse
|
9
|
Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study. Pathol Oncol Res 2017; 24:609-616. [DOI: 10.1007/s12253-017-0283-6] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2017] [Accepted: 08/02/2017] [Indexed: 12/18/2022]
|
10
|
Takeyama H, Sakiyama T, Wakasa T, Kitani K, Inoue K, Kato H, Ueda S, Tsujie M, Fujiwara Y, Yukawa M, Ohta Y, Inoue M. Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature. Oncol Lett 2017; 13:4290-4294. [PMID: 28599429 PMCID: PMC5452993 DOI: 10.3892/ol.2017.5983] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2016] [Accepted: 10/28/2016] [Indexed: 12/18/2022] Open
Abstract
Disseminated carcinomatosis of the bone marrow (DCBM) is a condition in which bone marrow (BM) metastases diffusely invade the BM, and is frequently accompanied by disseminated intravascular coagulation (DIC). While prostate, lung, breast and stomach malignancies, in addition to neuroblastoma, are the most prevalent non-hematological malignancies to metastasize frequently to the BM, colorectal cancer is a malignancy that rarely metastasizes to the BM. The present case describes a 65-year-old male patient treated by resection and one course adjuvant chemotherapy for stage IIIC rectal cancer who presented with nasal bleeding at 8 months post-surgery. A blood test exhibited DIC. A BM biopsy was performed and the definitive diagnosis was DCBM with DIC. Promptly, anti-DIC treatment and chemotherapy with a modified FOLFOX6 (folinic acid, leucovorin (LV), 5-fluorouracil (5-FU) and oxaplatin) regimen was started. Following 1 cycle of chemotherapy, DIC was improved and subsequent to 2 cycles of modified FOLFOX6 the patient was discharged. The patient was alive 263 days subsequent to the diagnosis of DIC, but succumbed to carcinomatous meningitis as a result of disease progression. To the best of our knowledge, this is the first report of DCBM with DIC of curatively resected rectal cancer as the first presentation of relapse that was successfully treated with aggressive therapy, including chemotherapy.
Collapse
Affiliation(s)
- Hiroshi Takeyama
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Tsutomu Sakiyama
- Department of Medical Oncology, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Tomoko Wakasa
- Department of Pathology, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Kotaro Kitani
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Keisuke Inoue
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Hiroaki Kato
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Shinya Ueda
- Department of Medical Oncology, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Masanori Tsujie
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Yoshinori Fujiwara
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Masao Yukawa
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Yoshio Ohta
- Department of Pathology, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| | - Masatoshi Inoue
- Department of Gastroenterological Surgery, Nara Hospital, Faculty of Medicine, Kinki University, Nara 630-0293, Japan
| |
Collapse
|
11
|
Kuczma P, Vidal Fortuny J, Essia S, de Lassus A, Morel P, Ris F. Odd localisation for a gastric cancer histology. Int J Surg Case Rep 2016; 27:51-54. [PMID: 27543724 PMCID: PMC4992006 DOI: 10.1016/j.ijscr.2016.07.028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2016] [Revised: 07/20/2016] [Accepted: 07/23/2016] [Indexed: 12/11/2022] Open
Abstract
More than 96% of signet-ring cell carcinomas occur in the stomach. Primary SRC carcinoma of the colon and rectum is very rare. It spreads mainly to the lymph nodes and to the peritoneum and rarely to the liver. It presents at advanced stages and has a dismal prognosis. Upper endoscopy is the investigation of choice to exclude a primary gastric cancer.
Introduction More than 96% of signet-ring cell carcinomas occur in the stomach and the rest in other organs, including the gallbladder, pancreas, urinary bladder and breast. Primary signet-ring cell carcinoma of the colon and rectum is very rare, accounting for 0.1%–2.4% of all colorectal cancers. Presentation of case We report a case of a 55-year old man who is operated for a caecal mass evocative of an appendicitis abscess. Intraoperatively, we discover a large, ulcerated ilio-caecal mass with several lymphadenopathies. The further workup reveals a primary signet-ring cell carcinoma of the colon with multiple lymph nodes and osteolytic bony metastases. Discussion Primary signet-ring cell carcinoma of the colon and rectum presents usually as an advanced stage disease with a dismal prognosis. It spreads mainly to the lymph nodes and to the peritoneum and very rarely to the liver. The mean age of patients diagnosed with primary signet-ring cell carcinoma is significantly younger than for ordinary adenocarcinoma. The upper endoscopy is the investigation of choice to exclude a primary gastric pathology. There are very few reports about this type of cancer and no reports about this type of cancer associated with osteolytic bony metastases. Conclusion The characteristics and pathophysiology of a primary signet-ring cell carcinoma of the colon and rectum are not well understood. Usually only palliative treatment is possible. The importance of an early diagnosis of this tumor is mandatory to have a curative approach.
Collapse
Affiliation(s)
- Paulina Kuczma
- Department of Visceral Surgery, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
| | - Jordi Vidal Fortuny
- Department of Visceral Surgery, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
| | - Saiji Essia
- Department of Pathology, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
| | - Ariane de Lassus
- Department of Pathology, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
| | - Philippe Morel
- Department of Visceral Surgery, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
| | - Frédéric Ris
- Department of Visceral Surgery, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.
| |
Collapse
|